<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Orthobiologics News: The Buzz from AAOS 2023

5/16/23 9:30 AM

Ortho Buzz AAOS 2023 v2Company efforts to grow share, reduce costs and increase revenue

This year’s American Academy of Orthopaedic Surgeon’s (AAOS) Annual Meeting was well attended, lively and appeared to be “getting back to normal.” The exhibit hall flowed with curious surgeons, industry symposiums and innovation talks were standing room only; the annual meeting was pulsating with robust information and industry news. Compared to previous years, the Orthobiologics buzz at AAOS 2023 was immense, and this article highlights some of the latest news.
 
Among the topics discussed in the complete Perspective article, which is available for download here, are:
  • Top of Mind: M&A and Workforce Reductions
  • Macroeconomic Headwinds
  • Momentum for Penetrating Larger Addressable Markets
  • Companies that are Shifting Strategies
    • Anika Therapeutics - Anika has been transforming itself from an osteoarthritis (OA) pain management leader with a huge addressable market to a ...
    • Vericel - US Cartilage Replacement Market leader Vericel continues to shape the market landscape and shift how surgeons are treating ...
    • CONMED - In 2021, CONMED accelerated investments to grow its domestic Orthopedic business, including expanding its ...
  • Latest Updates on Pricing and Reimbursement

In summary, this year’s AAOS meeting was energetic, and most of the news and information was positive. SmartTRAK is eager to see the outcomes of the recent acquisitions and activities associated with capturing more market share and ...

To read the complete "The Orthobiologics Buzz at AAOS 2023" article by Kimberly French, GM, Orthobiologics and Regenerative Medicine, just click the button below. Download the Orthobio Buzz AAOS 2023 Article


SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the em>SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

Topics: Orthobiologics

Kim French
Written by Kim French

20+ years of progressive medical device and biologics marketing and sales experience in orthopedic biological implants, cellular technologies and biopharmaceuticals. Most recent experience includes President, Trilogy Consulting and Marketing and Sales Management roles at AlloSource and Terumo BCT.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles